TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2024-06-04
劉俊人Liu, Chun-Jen
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
-
jiun0924@gmail.com
發表文獻
74筆
71
Yu LY, Hu KC, Liu CJ, Hung CL, Bair MJ, Chen MJ, Wang HY, Wu MS, Shih SC, Liu CC. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque. Medicine (Baltimore). 2019 Mar;98(9):e14672. doi: 10.1097/MD.0000000000014672. PMID: 30817593; PMCID: PMC6831312.
72
Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma. Aliment Pharmacol Ther. 2019 Mar;49(5):589-598. doi: 10.1111/apt.15132. Epub 2019 Jan 25. PMID: 30681172.
73
Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. Aliment Pharmacol Ther. 2019 Feb;49(3):331-339. doi: 10.1111/apt.15101. Epub 2018 Dec 27. PMID: 30592071.
74
Liu CJ, Tseng TC, Yang WT, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B. J Gastroenterol Hepatol. 2019 Feb;34(2):410-417. doi: 10.1111/jgh.14455. Epub 2018 Sep 20. PMID: 30151861.
